Proximagen Group PLC Holding(s) in Company (2657I)
July 23 2012 - 7:29AM
UK Regulatory
TIDMPRX
RNS Number : 2657I
Proximagen Group PLC
23 July 2012
TR-1:NOTIFICATION OF MAJOR INTEREST IN SHARES
------------------------------------------------------------------------------------
1. Identity of the issuer or the underlying Proximagen Group plc
issuer
of existing shares to which voting rights
are
attached: (ii)
--------------------------------------------------- -------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------------ ----
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
------------------------------------------------------------------------------ ----
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
------------------------------------------------------------------------------ ----
An event changing the breakdown of voting rights
------------------------------------------------------------------------------ ----
Other (please
specify):
-------------------- -------------------------------------------------------- ----
3. Full name of person(s) subject Upsher-Smith Laboratories, Inc.
to the
notification obligation: (iii)
--------------------------------------------- -------------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
--------------------------------------------- -------------------------------------
5. Date of the transaction and date 20 July 2012
on
which the threshold is crossed
or
reached: (v)
--------------------------------------------- -------------------------------------
6. Date on which issuer notified: 20 July 2012
--------------------------------------------- -------------------------------------
7. Threshold(s) that is/are crossed
or
reached: (vi, vii) 15%
--------------------------------------------- -------------------------------------
8. Notified details:
--------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------------------
Class/type of Situation previous Resulting situation after the triggering
shares to the triggering transaction
transaction
if possible
using
the ISIN CODE
--------------- ------------------------------------------ -------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
------------- -------------------- -------------------- ------------- ---------------------- ----------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ---- ----- ------- --- ------ ------- ------------- ------- ------------- --------- -----------
GB00B06FMX57 10,015,700 10,015,700 0 0 10,015,700 0% 15.87%
-------------------- -------------------- ------------- ------- ------------- --------- -----------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
--------------------- ------------------- ------------------------------ --------------------------- -----------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments (xv, xvi)
--------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date (xvii) Conversion rights instrument rights (xix,
instrument period refers to xx)
(xviii)
------------- ------------- -------------------- --------------- ------------------------ ---------------------------
Nominal Delta
------------- ------------- -------------------- --------------- ------------------------ ---------------- ---------
Total (A+B+C)
--------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------------------------- -----------------------------------------------------
10,015,700 15.87%
------------------------------------------------------------------- -----------------------------------------------------
9. Chain of controlled undertakings through which the voting rights
and/or the
financial instruments are effectively held, if applicable: (xxi)
----------------------------------------------------------------------------------
USL Pharma International UK Limited is a direct, wholly-owned subsidiary
of Upsher-Smith Laboratories, Inc.
Pursuant to the transaction notified in this form, USL Pharma International
UK Limited has acquired 10,015,700 shares in Proximagen Group plc (with
all voting rights attached thereto) from Upsher-Smith Laboratories,
Inc.
Proxy Voting:
----------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------ --------------------------
11. Number of voting rights proxy holder will
cease
to hold:
------------------------------------------------------ --------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
------------------------------------------------------ --------------------------
13. Additional information:
------------------------------------------ --------------------------------------
14. Contact name: Stephen M. Robinson
------------------------------------------ --------------------------------------
15. Contact telephone number: +1 763 315 2000
------------------------------------------ --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUOUARUWABUAR
Proximagen Neuroscience (LSE:PRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Proximagen Neuroscience (LSE:PRX)
Historical Stock Chart
From Apr 2023 to Apr 2024
